SCHEMBL10270189

SCHEMBL10270189

CC1CCN(CCc2nc3cc(-c4ccc(Cl)cc4Cl)nc(NCCNc4ccc(N)c(N)n4)n3n2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.36
GSK3A P49840 2/20 0.36
ADORA2A P29274 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
DPP4 P27487 2/20 0.31
DPP8 Q6V1X1 2/20 0.31
DPP9 Q86TI2 1/20 0.31
PRCP P42785 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
LMNA P02545 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
MAPK1 P28482 1/20 0.30
MEN1 O00255 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12680861 0.91 GSK3B (0.36) GSK3BGSK3AADORA2ACYP1A2CYP2D6
SCHEMBL10270029 0.84 GSK3B (0.36) GSK3BGSK3ACYP2C9CYP2C19DPP4
SCHEMBL12681520 0.83 GSK3B (0.39) GSK3BADORA2ADPP4DPP8DPP9
SCHEMBL12680853 0.83 GSK3B (0.47) GSK3BADORA2AMAOAMAOB
SCHEMBL10270318 0.82 ALDH1A1 (0.36) GSK3BGSK3AADORA2ACYP1A2CYP2D6
SCHEMBL12680493 0.80 CYP1A2 (0.41) ADORA2ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8006538 0.79 GSK3B (0.34) GSK3BGSK3ACYP1A2CYP2D6CYP2C9
SCHEMBL12680465 0.78 CYP1A2 (0.40) ADORA2ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL10270758 0.78 GSK3B (0.34) GSK3BGSK3ACYP2C9CYP2C19DPP4
SCHEMBL10270037 0.77 GSK3B (0.36) GSK3BGSK3ACYP2C9CYP2C19DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137188-B1 SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES Bayer Pharma AG (DE) 2012-06-06 EP disclosed